Global Immunoassay Systems Market to Reach $29.9 Billion by 2030
The global market for Immunoassay Systems estimated at US$22.1 Billion in the year 2022, is projected to reach a revised size of US$29.9 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2022-2030. Reagents & Kits, one of the segments analyzed in the report, is projected to record a 3.8% CAGR and reach US$19.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Analyzers / Instruments segment is readjusted to a revised 3.1% CAGR for the next 8-year period.The U.S. Market is Estimated at $6 Billion, While China is Forecast to Grow at 6.6% CAGR
The Immunoassay Systems market in the U.S. is estimated at US$6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$6.2 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1% and 4.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4 Billion by the year 2030.Select Competitors (Total 29 Featured) -
- Abbott Laboratories
- Beckman Coulter Inc.
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- DiaSorin S.p.A
- Ortho-Clinical Diagnostics Inc.
- Quidel Corporation
- Roche Diagnostics
- Siemens Healthineers
- Sysmex Corporation
- Tosoh Bioscience Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARYIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Beckman Coulter Inc.
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- DiaSorin S.p.A
- Ortho-Clinical Diagnostics Inc.
- Quidel Corporation
- Roche Diagnostics
- Siemens Healthineers
- Sysmex Corporation
- Tosoh Bioscience Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 267 |
Published | May 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 22.1 Billion |
Forecasted Market Value ( USD | $ 29.9 Billion |
Compound Annual Growth Rate | 3.9% |
Regions Covered | Global |